Fingolimod and risk of skin cancer among individuals with multiple sclerosis: a population-based cohort study protocol | BMJ Open

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Log out
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

For authors

About

Browse by collection
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

You are viewing from: Department GEZ-LTA Erasmushogeschool

Citation Tools

Neurology

Protocol

Fingolimod and risk of skin cancer among individuals with multiple sclerosis: a population-based cohort study protocol

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Jia A, Kuramoto L, Khakban A, et al

Fingolimod and risk of skin cancer among individuals with multiple sclerosis: a population-based cohort study protocol

BMJ Open 2025;15:e088924. doi: 10.1136/bmjopen-2024-088924